These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7021412)

  • 1. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study.
    Overlack A; Stumpe KO; Kolloch R; Ressel C; Krueck F
    Hypertension; 1981; 3(3 Pt 2):I18-21. PubMed ID: 7021412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension.
    Bönner G; Toussaint C; Claus M; Fritschka E; Philipp T; Vetter H; Feltkamp H
    Agents Actions Suppl; 1992; 38 ( Pt 3)():294-303. PubMed ID: 1462864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Kolloch R; Zywzok W; Krück F
    Klin Wochenschr; 1980 Jan; 58(1):37-42. PubMed ID: 6900133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Krück F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein.
    Oliveros-Palacios MC; Godoy-Godoy N; Colina-Chourio JA
    Am J Cardiol; 1991 Jan; 67(2):157-61. PubMed ID: 1824806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.
    Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral administration of extracted kallikrein to patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Ferri C; Luparini RL; Germanò G; Giarrizzo C; Santucci A; Balsano F
    Clin Ter; 1991 Oct 15-31; 139(1-2):3-8. PubMed ID: 1837764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.
    Bellini C; Ferri C; Piccoli A; Carlomagno A; Di Francesco L; Bonavita MS; Santucci A; Balsano F
    Nephron; 1993; 65(1):28-35. PubMed ID: 8413787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and tolerance of orally administered kallikrein in patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Torregrossa G; Leonetti Luparini R; Germanò G; Giarrizzo C; Ferri C; Santucci A
    Ann Ital Med Int; 1991; 6(4):369-74. PubMed ID: 1804283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril.
    Madeddu P; Oppes M; Rubattu S; Bandiera F; Dessi'-Fulgheri P; Glorioso N; Soro A; Chiara-Troffa M; Rappelli A
    Agents Actions Suppl; 1987; 22():321-8. PubMed ID: 3324715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defect in kallikrein-kinin-system in essential hypertension and reduction of blood pressure by orally given kallikrein.
    Overlack A; Stumpe KO; Zywzock W; Ressel C; Drück F
    Adv Exp Med Biol; 1979; 120B():539-47. PubMed ID: 517248
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
    Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of kallidinogenase on urinary kallikrein excretion and plasma prostanoid concentrations in patients with essential hypertension.
    Ogawa K; Ito T; Ban M; Motizuki M; Satake T
    Experientia; 1986 Sep; 42(9):1014-5. PubMed ID: 3639011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of central alpha 1 inhibition in patients with essential hypertension.
    Lijnen P; Staessen J; Fagard R; Amery A
    Chest; 1983 Feb; 83(2 Suppl):371-3. PubMed ID: 6129952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.